Literature DB >> 301401

Acid esterase in human lymphoid cells and leukaemic blasts: a marker for T lymphocytes.

J Kulenkampff, G Janossy, M F Greaves.   

Abstract

A non-specific acid alpha-naphthyl-acetate esterase activity was investigated in human lymphoid cell populations from tonsils, blood, thymus and in different leukaemias. Four patterns have emerged. (i) The vast majority of T lymphocytes (peripheral blood, tonsils) showed a localized, intense reaction product ("T-like"). (ii) A thymocyte subpopulation expressed faint, localized enzyme activity ("Thy-like) but the majority of thymocytes showed no esterase activity. Some cells from acute lymphoblastic leukaemias with thymocyte surface characteristics had a "Thy-like" appearance. (iii) Most B lymphocytes and cells from chronic lymphocytic leukaemias were esterase negative. No activity was seen in mitogen activated peripheral blood T and B lymphoblasts from peripheral blood and in leukaemic blasts from the common form of childhood acute "lymphoblastic" leukaemia. (iv) Myeloid cells, including peripheral blood monocytes, and blast cells from acute myeloblastic and chronic granulocytic leukaemias showed an intense, diffuse reaction product (M-like). It is concluded that the modified esterase technique is a convenient marker for small mature human T lymphocytes in tissue sections and smears. It may also be helpful in the differential diagnosis of acute lymphoblastic leukaemia with T characteristics, the common form of acute "lymphoblastic" leukaemia and acute myeloblastic leukaemia.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 301401     DOI: 10.1111/j.1365-2141.1977.tb00644.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  39 in total

1.  Histochemical studies on chicken peripheral blood lymphocytes.

Authors:  N K Maiti; S S Saini; S N Sharma
Journal:  Vet Res Commun       Date:  1990       Impact factor: 2.459

2.  Cytochemical identification of human T-lymphocytes.

Authors:  R D Barr; M Allardyce
Journal:  Can Med Assoc J       Date:  1978-05-20       Impact factor: 8.262

3.  Cathepsin D activity in human peripheral blood mononuclear leukocytes.

Authors:  C T Bever; K D Morgan; J N Whitaker
Journal:  Inflammation       Date:  1989-06       Impact factor: 4.092

4.  Vincristine infusion. A phase I study.

Authors:  W Weber; G A Nagel; E Nagel-Studer; R Albrecht
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

Review 5.  Malignant lymphomas--a conceptual understanding of morphologic diversity. A review.

Authors:  R B Mann; E S Jaffe; C W Berard
Journal:  Am J Pathol       Date:  1979-01       Impact factor: 4.307

6.  Assessment of host defence against infection during chemotherapy of Hodgkin's disease.

Authors:  I Addison; J Babbage; M Gandossini; R Souhami
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

7.  T-cell nature of leukaemic cells in a case of Sézary's syndrome with 'null-cell' features.

Authors:  L Lauriola; P Musiani; A Carbone; M Bartolini; P Cianciulli; M Piantelli
Journal:  J Clin Pathol       Date:  1979-09       Impact factor: 3.411

8.  alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.

Authors:  G S Pinkus; H K Hargreaves; J A McLeod; L M Nadler; D S Rosenthal; J W Said
Journal:  Am J Pathol       Date:  1979-10       Impact factor: 4.307

9.  Acid alpha-naphthyl acetate esterase activity in human neoplastic lymphoid cells. Usefulness as a T-cell marker.

Authors:  D M Knowles; J P Halper; G A Machin; W Sherman
Journal:  Am J Pathol       Date:  1979-07       Impact factor: 4.307

10.  The role of TG lymphocytes in cell-mediated immunity in patients with periodontal disease.

Authors:  L Ivanyi; B Topic; P M Lydyard
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.